|
 |
Below you will find speaker information from the September 17th, 2005 NSABP Satellite Symposium.
To the right of each speaker you will find links to their respective PowerPoint presentations for view or download. |
 |
|
|
|
|
 |
Edward H Romond, MD
Professor of Medicine
Division of Hematology/Oncology
Markey Cancer Center
University of Kentucky
Lexington, Kentucky |
|
B-31/N9831
First Interim Joint Analysis |
| |
 |
|
|
 |
Dennis J Slamon, MD, PhD
Professor of Medicine
Chief, Division of Hematology/Oncology
Director of Clinical/Translational Research
Jonsson Comprehensive Cancer Center
David Geffen School of Medicine at UCLA
Los Angeles, California |
|
BCIRG006 Phase III Trial |
| |
|
|
|
 |
Brian Leyland-Jones, MD, PhD
Minda de Gunzburg Professor
Department of Oncology
McGill University
Montreal, Quebec |
HERA: Key Design Elements, Results
and Future Plans |
| |
|
|
|
 |
Peter A Kaufman, MD
Associate Professor of Medicine
Section of Hematology/Oncology
Dartmouth-Hitchcock Medical Center
Comprehensive Breast Care Program
Norris Cotton Cancer Center
Lebanon, New Hampshire |
|
NCCTG N9831
May 2005 Update |
| |
|
|
|
 |
Charles E Geyer Jr, MD
Director of Medical Affairs
National Surgical Adjuvant Breast and
Bowel Project
Director of Breast Medical Oncology
Allegheny General Hospital
Pittsburgh, Pennsylvania |
| |
Cardiac Toxicity on
NSABP B-31 |
| |
|
|
|
|
| |
|
|
|
